Mammen Mathai
Insider transactions at 4 companies
This page shows all SEC Form 4 filings attributed to Mammen Mathai. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TXG | Award / Grant | 8,649 | — | — | Jun 11, 2024 | |
| TXG | Award / Grant | 1,865 | — | — | Jun 14, 2023 | |
| TXG | Sale | 33,000 | $52.82 | $1,743,060 | May 11, 2023 | |
| TXG | Award / Grant | 2,120 | — | — | Jun 15, 2022 | |
| JNJ | EVP, Pharm, R&D | Tax Withholding | 3,366 | $165.89 | $558,386 | Feb 15, 2022 |
| JNJ | EVP, Pharm, R&D | Option Exercise | 7,418 | — | — | Feb 14, 2022 |
| TXG | Award / Grant | 625 | — | — | Jun 11, 2021 | |
| TBPH | SVP, Research & Development | Award / Grant | 90,000 | — | — | Mar 15, 2016 |
| TBPH | SVP, Research & Development | Tax Withholding | 19,844 | $15.65 | $310,559 | Feb 20, 2016 |
| TBPH | SVP, Research & Development | Tax Withholding | 934 | $17.17 | $16,037 | Nov 20, 2015 |
| TBPH | SVP, Research & Development | Tax Withholding | 934 | $12.98 | $12,123 | Aug 20, 2015 |
| TBPH | SVP, Research & Development | Tax Withholding | 7,360 | $13.83 | $101,789 | Jun 2, 2015 |
| TBPH | SVP, Research & Development | Tax Withholding | 673 | $14.24 | $9,584 | May 20, 2015 |
| TBPH | SVP, Research & Development | Tax Withholding | 674 | $19.52 | $13,156 | Feb 20, 2015 |
| TBPH | SVP, Research & Development | Award / Grant | 130,000 | — | — | Feb 5, 2015 |
| TBPH | SVP, Research & Early Clin Dev | Tax Withholding | 658 | — | — | Nov 20, 2014 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 3,261 | $22.76 | $74,220 | Aug 20, 2014 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 28,365 | — | — | Jun 16, 2014 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 50,000 | — | — | Jun 2, 2014 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 37,500 | — | — | Apr 27, 2014 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 22,833 | $26.86 | $613,294 | Mar 13, 2014 |
| INVA | SVP, Research & Early Clin Dev | Option Exercise | 12,903 | $12.40 | $159,997 | Mar 6, 2014 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 4,307 | $39.98 | $172,194 | Feb 20, 2014 |
| INVA | SVP, Research & Early Clin Dev | Sale | 30,400 | $39.26 | $1,193,504 | Feb 14, 2014 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 4,569 | $36.40 | $166,312 | Nov 20, 2013 |
| INVA | SVP, Research & Early Clin Dev | Gift | 450 | — | — | Oct 3, 2013 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 3,813 | $35.89 | $136,849 | Aug 21, 2013 |
| INVA | SVP, Research & Early Clin Dev | Sale | 7,000 | $36.51 | $255,570 | Jul 30, 2013 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 5,000 | — | — | Jul 24, 2013 |
| INVA | SVP, Research & Early Clin Dev | Option Exercise | 4,570 | $3.10 | $14,167 | May 29, 2013 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 3,292 | $37.01 | $121,837 | May 20, 2013 |
| INVA | SVP, Research & Early Clin Dev | Sale | 6,800 | $33.72 | $229,296 | Apr 30, 2013 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 5,002 | $22.10 | $110,544 | Feb 20, 2013 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 5,000 | — | — | Feb 7, 2013 |
| INVA | SVP, Research & Early Clin Dev | Option Exercise | 11,855 | $3.10 | $36,751 | Jan 11, 2013 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 4,874 | $21.08 | $102,744 | Nov 20, 2012 |
| INVA | SVP, Research & Early Clin Dev | Option Exercise | 5,161 | $3.10 | $15,999 | Nov 14, 2012 |
| INVA | SVP, Research & Early Clin Dev | Sale | 6,800 | $21.42 | $145,656 | Nov 2, 2012 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 5,000 | — | — | Oct 15, 2012 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 4,644 | $27.01 | $125,434 | Aug 20, 2012 |
| INVA | SVP, Research & Early Clin Dev | Sale | 21,892 | $25.68 | $562,187 | Aug 13, 2012 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 3,832 | $20.33 | $77,905 | May 20, 2012 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 9,747 | $18.54 | $180,709 | Feb 20, 2012 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 5,000 | — | — | Feb 15, 2012 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 2,250 | $22.34 | $50,265 | Nov 20, 2011 |
| INVA | SVP, Research & Early Clin Dev | Option Exercise | 3,225 | $8.53 | $27,509 | Sep 1, 2011 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 2,248 | $17.50 | $39,340 | Aug 20, 2011 |
| INVA | SVP, Research & Early Clin Dev | Tax Withholding | 2,245 | $25.48 | $57,203 | May 20, 2011 |
| INVA | SVP, Research & Early Clin Dev | Sale | 3,701 | $23.12 | $85,567 | Feb 20, 2011 |
| INVA | SVP, Research & Early Clin Dev | Award / Grant | 12,500 | — | — | Feb 11, 2011 |